Medicines Discovery Catapult Limited

Reference number: 1014958

Instant download

Introducer appointed representative

This firm can only introduce you to its principal, and cannot give financial advice, recommend products, or arrange deals alone.

What does this mean?
  • An introducer appointed representative can only pass your details to its principal firm. It cannot recommend products, give financial advice, or arrange deals on its own.
  • MEDICINES DISCOVERY CATAPULT LIMITED (FRN 1014958) introduces customers to Cycle Solutions (Cycle to Work) Limited (FRN 722968). Any regulated advice or arranging is done by the principal, not MEDICINES DISCOVERY CATAPULT.
  • Example: if MEDICINES DISCOVERY CATAPULT refers you to a financial adviser, the advice should come from the principal firm, not from MEDICINES DISCOVERY CATAPULT itself.
  • Before you proceed, confirm contact details match the official FCA register for both firms. Scammers sometimes clone legitimate AR names and FRNs but use fake phone numbers and websites.

Website, phone number and address

Compare these against whatever you were given. Scammers clone real firm names and reference numbers but use their own phone number and website, so a detail that does not match the register is the clearest warning sign there is.

  • No website on the FCA register

  • Phone number

    07787 431693

  • Address

    Mereside, Alderley Park, Macclesfield, Cheshire East, SK10 4ZF, United Kingdom

In the full report: 2 background checks

  • What kind of line 07787 431693 is
  • Who else gives the postcode SK10 4ZF
Instant PDF download

FCA permissions and consumer protection

  • Protection through the principal firm
    Protection works through Cycle Solutions (Cycle to Work) Limited, the principal firm responsible for this firm's regulated activity. FSCS cover and the Financial Ombudsman Service apply as they would to the principal.
  • Complaints Ombudsman, free
    You can refer a complaint about this firm to the Financial Ombudsman Service for free, whichever activity it relates to.

FCA disciplinary action and complaints

No FCA disciplinary action.

The Financial Ombudsman Service only publishes complaint figures for firms with 30 or more new complaints in six months, so there are none here for this firm.

Companies House record

The company behind the firm: its status, age, registered office and directors.

Company status
Active
Company type
Private company limited by guarantee
Incorporated
23 December 2015 (10 years old)
Registered office
Block 35g, Mereside Alderley Park, Alderley Edge, Macclesfield, Cheshire, SK10 4ZF, England
Nature of business
  • Research and experimental development on biotechnology (SIC 72110)

Directors and company secretaries

Name Role Born Appointed Other companies
Robin John Brown (Dr) Director Oct 1960 27 Jul 2018 2 other companies
Lynne Robb Director Nov 1963 1 Jan 2019 4 other companies
Susan Jean Wallcraft Director Apr 1966 1 Apr 2020 None
Graham John Clarke Director Mar 1956 1 Apr 2020 9 other companies
Paul Vernon Edward Beastall Director Sep 1972 3 Nov 2022 7 other companies
Michael Anthony John Ferguson Director Feb 1957 1 Jan 2025 6 other companies
John Burn Director Feb 1952 1 Jan 2025 None
Michael Edward Strange (Dr) Director Jun 1970 28 Jan 2026 4 other companies
Laura Margaret Fletcher (Dr) Director Sep 1975 3 Aug 2026 6 other companies
Amira Modi Director Sep 1980 3 Aug 2026 1 other company
Robert Sherville-Payne Secretary Not published 3 Nov 2022 –

Other companies run by these 10 directors

A firm is run by people, and their other companies are their track record: what they built, what closed, and anything that failed. It is the check most people never think to make.

other companies
33
closed down
8
went insolvent
1

In the full report: all 33 companies, named

  • What each company does, and whether it is still trading
  • Which of these 10 directors sit on each board, and since when
  • The one that went into liquidation or administration
  • The 4 companies these 10 directors run together
  • All 22 people who have ever been directors, with their dates
Instant PDF download

Key dates in its history

Medicines Discovery Catapult’s history from the FCA register and Companies House, newest first.

2024

2 June 2024

  • Became an introducer appointed representative

FCA register

2021

13 April 2021

  • Christopher Richard Molloy no longer holds 25–50% of the votes
  • Robin John Brown no longer holds 25–50% of the votes

Companies House

2020

17 September 2020

  • Christopher Richard Molloy gained 25–50% of the votes

Companies House

2018

31 December 2018

  • Robert Kenneth Bryan gave up control

Companies House

27 July 2018

  • Robin John Brown gained 25–50% of the votes

Companies House

24 May 2018

  • Graham John Boulnois no longer holds 25–50% of the votes

Companies House

12 February 2018

  • Graham John Boulnois gained 25–50% of the votes

Companies House

2016

6 April 2016

  • Robert Kenneth Bryan took control (75–100% of votes)

Companies House

2015

23 December 2015

  • Incorporated at Companies House

Companies House

In the full report: all 44 events

  • All 44 events in its history (10 shown here)
  • Every director appointment and resignation: 34
Instant PDF download

Get the full report on Medicines Discovery Catapult

Everything on this page, plus everything locked above, in one dated PDF you can keep, file or send on.

  • 33 other companies its directors have run, named
  • 2 background checks on its contact details
  • All 44 events in its history

Instant PDF One-off payment Secure checkout by Stripe

Frequently asked questions about this firm

Is Medicines Discovery Catapult Limited FCA authorised?
Medicines Discovery Catapult Limited (FRN 1014958) is not directly authorised. It is an appointed representative acting under the responsibility of a directly authorised principal firm.
What does introducer appointed representative mean for Medicines Discovery Catapult?
An introducer appointed representative can only pass your details to its principal firm. It cannot recommend products, give financial advice, or arrange deals on its own. Medicines Discovery Catapult Limited (FRN 1014958) introduces customers to Cycle Solutions (Cycle to Work) Limited (FRN 722968). Any regulated advice or arranging is done by the principal, not Medicines Discovery Catapult. Example: if Medicines Discovery Catapult refers you to a financial adviser, the advice should come from the principal firm, not from Medicines Discovery Catapult itself. Before you proceed, confirm contact details match the official FCA register for both firms. Scammers sometimes clone legitimate AR names and FRNs but use fake phone numbers and websites.
What is Medicines Discovery Catapult’s phone number?
The FCA register lists the phone number 07787 431693 for Medicines Discovery Catapult. If you were given different contact details, use these to check with the firm before going any further.
Is Medicines Discovery Catapult a scam or clone?
Medicines Discovery Catapult is a genuine FCA-listed firm, and the FCA has published no warnings about fake versions of it. Scammers do copy real firms, though, so check that any contact details you were given match the ones on the register.
Is my money safe with Medicines Discovery Catapult?
Protection works through Cycle Solutions (Cycle to Work) Limited, the principal firm responsible for Medicines Discovery Catapult's regulated activity. FSCS cover and the Financial Ombudsman Service apply as they would to the principal.
Who owns Medicines Discovery Catapult?
Companies House lists no one with significant control of Medicines Discovery Catapult now. Before that, it was controlled by Mr Robert Kenneth Bryan, Professor Graham John Boulnois and Professor Christopher Richard Molloy.
Who runs Medicines Discovery Catapult?
Companies House lists 10 directors of Medicines Discovery Catapult: Robin John Brown (Dr), Lynne Robb, Susan Jean Wallcraft, Graham John Clarke, Paul Vernon Edward Beastall, Michael Anthony John Ferguson and 4 more.
How long has Medicines Discovery Catapult been in business?
The company was formed on 23 December 2015.

Sources and links

The full report on Medicines Discovery Catapult Limited

£19.99 · Instant PDF download

Loading secure checkout…